Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers | Phase1 | Belgium China France Germany Israel Italy Japan Korea, Republic of Norway Singapore Spain Sweden Taiwan United Kingdom United States View All |
NCT05838768 |
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). |
Systemic Lupus Erythematosus | Phase3 | Argentina Australia Bulgaria Canada China Czechia France Germany Guatemala Hungary Japan Malaysia Poland Portugal Romania Spain Taiwan Thailand United States View All |
NCT06133972 |
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France |
Chronic Myeloid Leukemia | France | NCT06092879 | |
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer |
Breast Cancer | Phase1 | China France Germany Poland Portugal Spain United States View All |
NCT05870579 |
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL |
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma | Phase1, Phase2 | Australia Austria France Germany Italy Japan Spain United States View All |
NCT03960840 |
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS |
Atypical Hemolytic Uremic Syndrome | Phase3 | Brazil China Czechia India View All |
NCT05795140 |
Kesimpta (Ofatumumab) Pregnancy Registry |
Multiple Sclerosis, Pregnancy | United States | NCT05634967 | |
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection |
Melanoma | China | NCT04666272 | |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
Metastatic Uveal Melanoma | Phase1, Phase2 | Australia France Germany Netherlands Spain Switzerland United States View All |
NCT05415072 |
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors |
Mesothelioma | Phase1 | Australia Canada France Germany Italy Japan Netherlands Spain Switzerland United Kingdom United States View All |
NCT04857372 |